Study outcomes | Baseline | 1 year | 3 years |
---|---|---|---|
Combined remission | 6 (60%) | 7 (60%) | |
Response* | 2 (20%) | 0 (0%) | |
No response | 2 (20%) | 3 (30%) | |
PDAI score† | 7.3 ± 2.7 | 3.4 ± 4.3 | 7.2 ± 5.2 |
SIBDQ score‡ | 43.4 ± 11.9 | 47.0 ± 11.4 | 49.0 ± 13.2 |
MAGNIFI-CD score | Baseline | 1 year | 3 years |
---|---|---|---|
All patients (n = 10) | |||
IRM total score | 17.8 ± 4.9 | 16.2 ± 6.1 | 14.7 ± 5.7 |
Change from baseline | − 1.6 ± 3.1 | − 3.1 ± 3.3 | |
Patients in remission at 3 years (n = 7) | |||
IRM total score | 16.8 ± 5.9 | 14.3 ± 6.0 | 11.5 ± 4.3 |
Change from baseline | −2.5 ± 2.4 | −5.3 ± 1.8 | |
Patients without response at 3 years (n = 3) | |||
IRM total score | 19.3 ± 3.0 | 19.0 ± 5.8 | 19.5 ± 4.0 |
Change from baseline | 0.3 ± 3.9 | 0.3 ± 1.3 |